Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

105.92 +1.00 (+0.95%)
Official Closing Price Updated: 7:00 PM EDT, Mar 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Merck & Co

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
46 47 Next >
2 Top Biotech Stocks to Buy Right Now
These two rank among the 10 largest pharmaceutical companies on the planet. 
Via The Motley Fool
3 Bargain Stocks You Can Buy Today and Hold Forever
The low price only matters if the underlying company can be rebuilt as needed. 
Via The Motley Fool
Credit Suisse Believes In This Pharma Giant's Low Risk Growth Against Uncertain Backdrop
 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
Upgrades 
Via Benzinga
Here's How Much You Would Have Made Owning Merck & Co Stock In The Last 5 Years
 
Via Benzinga
What 13 Analyst Ratings Have To Say About Merck & Co
 
Via Benzinga
Analyst Expects 'Somewhat Smaller Effect Size' From Gossamer Bio's Upcoming PAH Trial
 
Via Benzinga
A Look Into Merck & Co's Debt
Over the past three months, shares of Merck & Co's Inc. (NYSE:MRK) moved higher by 13.30%. Before we understand the importance of debt, let's look at how much debt Merck & Co's has. 
Via Benzinga
How Long Can This Top Stock Continue Defying the Bear Market?
It could only be the beginning for this pharma giant. 
Via The Motley Fool
4 Reasons to Buy This Hybrid of a Growth and Income Stock
This drugmaker's dividend yield is currently well above the average yield among S&P 500 stocks. 
Via The Motley Fool
Merck & Co Unusual Options Activity
Someone with a lot of money to spend has taken a bullish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
FTX Contagion Spreads To Hong Kong Exchange, Microsoft Outlines New Harassment Policies, Netflix Subscribers Can Terminate Freeloading Account Access: Top Stories Wednesday, Nov. 16
Benzinga 
Via Benzinga
Is Merck Too Dependent on Keytruda?
The company's top-selling drug brought in the most revenue last quarter and was also its fastest-growing product. 
Via The Motley Fool
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
 
Via Benzinga
7 Value Stocks to Buy Before They Pop Off
Data shows that it's time for investors to abandon the largest Big Tech names and find attractive value stocks to buy. 
Via InvestorPlace
Dow Drops 211 Points As Stocks Struggle For Direction
Stocks looked like they were going to extend Friday's impressive wins, but wound up falling lower by the close. 
Via Talk Markets
European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs
 
Via Benzinga
These 2 Dividend Paying ETFs Have A Track Record For Increasing Payments, Can Help Diversify Against Industry Risk
Investing in an exchange-traded fund that invests in large cap dividend stocks can be a great way to secure passive income. 
Via Benzinga
Will Merck Continue Its Bullish Streak? A Wyckoff Analysis
According to the Wyckoff trading method, Merck's price structure is bullish with enough causes built over the years and lack of threatening supply. 
Via Talk Markets
Why Are Healthcare Stocks Down Today?
Healthcare stocks are falling after a false tweet from a Twitter account impersonating Eli Lilly. Here's what this news means for investors. 
Via InvestorPlace
This Is What Whales Are Betting On Merck & Co
A whale with a lot of money to spend has taken a noticeably bullish stance on Merck & Co. Looking at options history for Merck & Co (NYSE:MRK) we detected 19 strange trades. 
Via Benzinga
SELLAS Life Sciences' GPS Combo Therapy Shows Overall Survival Of 18 Months In Pretreated Ovarian Cancer Patients
 
Via Benzinga
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles
Biogen jumped after naming Christopher Viehbacher its CEO. David Epstein will take over at Seagen. 
Via Investor's Business Daily
Buy Bristol-Myers Squibb, Merck, 10-Year Treasury ETF And This Payments Stock: CNBC's 'Final Trades'
On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners chose Bristol-Myers Squibb Co. (NYSE: BMY) as his final trade. 
Via Benzinga
Stocks Sharply Lower As Political Gridlock Sets In
Stocks sold off today, falling victim to the likelihood of a political gridlock in Washington D.C. 
Via Talk Markets
7 No-Brainer Retirement Stocks to Buy for 2023 and Beyond
These no-brainer retirement stocks have proven to be amazingly consistent in delivering incredible returns for investors over time. 
Via InvestorPlace
Election Day Is Here: Which Politicians Are Profiting (Or Losing) On Stocks?
U.S. voters will spend the majority of Tuesday casting their ballots for the candidates they want to represent them in Congress, which consists of the House of Representatives and the Senate. 
Via Benzinga
These 3 Dividend ETFs Are a Retiree's Best Friend
This trio of exchange-traded funds has trounced the S&P 500 this year. 
Via The Motley Fool
Control Of Congress Up For Grabs In Midterms: 12 Stocks To Watch
As voters endeavor to select the congressional candidates they believe would best assist the U.S. in navigating through historical issues it is currently facing, investors are wondering what's going to... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
46 47 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.